Dysferlin在妊娠期高血压疾病孕妇血清、脐血和胎盘组织中的表达及其意义

doi:10.3969/j.issn.1671-7171.2020.06.005

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the expression and significance of transmembrane protein Dysferlin in serum, cord blood and placental tissue of pregnant women with gestational hypertension. 【Methods】A total of 66 pregnant women with pregnancy-induced hypertension, who were hospitalized in our department from August 2017 to February 2019, were selected and divided into pregnancy-induced hypertension group (22 cases), preeclampsia group (22 cases) and eclampsia group (22 cases) according to the severity of pregnant women. In the same time period, 22 normal pregnant volunteers (full term delivery without complications) were enrolled for the control group. The expression of Dysferlin in serum and umbilical cord blood of the four groups of pregnant women was detected by ELISA. Immunohistochemistry (SP method) was used to detect the expression of Dysferlin in placental tissues of 4 groups. 【Results】Compared to the control group and the gestational hypertension group, Dysferlin expression levels in serum and umbilical cord blood in the pre-eclampsia group and the eclampsia group were significantly reduced, and the differences were statistically significant (P<0.05). In comparison with preeclampsia, Dysferlin expression in serum and umbilical cord blood in the eclampsia group was significantly decreased, and the difference was statistically significant (P<0.05). The results of immunohistochemistry showed that the positive expression rate of Dysferlin in placenta of all four groups were not statistically significant difference (P>0.05). 【Conclusion】The expression of Dysferlin is different depending on the severity of pregnancy-induced hypertension. Clinical monitoring of Dysferlin levels in serum and umbilical cord blood can provide a reference for the diagnosis and treatment of gestational hypertension.

Key words： Hypertension,Pregnancy-Induced Pregnant Women

Received: 27 December 2018

PACS:

R581.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2020.06.005 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2020/V37/I6/816

[1] 王芳.可溶性血管内皮生长因子受体sFlt-1、Flt-1在妊娠期高血压疾病患者中的水平和意义[J].医学综述,2014,20(6):1136-1138.
[2] 史许锋. 胎盘组织中KDM5C、BMP-7的表达及与重度子痫前期发病关系的研究[D].郑州大学, 2017.
[3] 阮志平. 硬膜外分娩镇痛对妊娠期高血压产妇分娩结局的影响[J].医学临床研究, 2019, 36(10): 1988-1989.
[4] Redman CW . Latest advances in understanding preeclampsia[J].Science,2005, 308(5728):1592-1594.
[5] Naderi S, Tsai SA, Khandelwal A. Hypertensive disorders of pregnancy[J].Curr Atheroscler Rep,2017, 19(3):15.
[6] Nagaraju K, Rawat R, Veszelovszky E, et al. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B[J].Am J Pathol,2008, 172(3):774-785.
[7] 黄巧婷, 许杰, 林家仕. 运动性骨骼肌损伤大鼠膜修复蛋白dysferlin的作用机制[J].中国组织工程研究, 2018,22(16):2502-2507.
[8] Vincent AE, Rosa HS, Alston CL, et al. Dysferlin mutations and mitochondrial dysfunction[J].Neuromuscul Disord,2016, 26(11):782-788.
[9] 谢幸, 苟文丽, 林仲秋,等.妇产科学[M]. 第8版. 北京:人民卫生出版社, 2013:64-71.
[10] 王芳. Dysferlin、Affixin在子痫前期患者母血及胎盘组织中的表达及其意义[D].河北医科大学, 2016.
[11] 郑丹. Dysferlin在子痫前期发病机制中的研究[J].江西医药, 2012, 47(11):1017-1019.
[12] 万家晗. ARID1A和CD133蛋白在肝细胞肝癌中的表达及意义[D].郑州大学,2016.
[13] Han R , Campbell KP. Dysferlin and muscle membrane repair[J].Curr Opin Cell Biol,2007, 19(4):409-416.
[14] Cárdenas AM, González-Jamett AM, Cea LA, et al. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies[J].Exp Neurol,2016, 283(Pt A):246-254.
[15] Han R , Bansal D , Miyake K , et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury [J].J Clin Invest,2007, 117(7):1805-1813.
[16] 郑丹. 质膜修复蛋白和半胱氨酸天冬氨酸蛋白酶-3在妊娠期高血压疾病胎盘组织中的表达及其意义[D].南昌大学医学院, 2014.